The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Population-Attributable Fractions of Risk Factors for Hepatocellular Carcinoma in the United States
Open accessAbstract
OBJECTIVES: Risk factors for hepatocellular carcinoma (HCC) include hepatitis B and C viruses (HBV, HCV), excessive alcohol consumption, rare genetic disorders and diabetes/obesity. The population attributable fractions (PAF) of these factors, however, have not been investigated in population-based studies in the United States. METHODS: Persons ≥68 years diagnosed with HCC (n=6,991) between 1994 and 2007 were identified in the SEER-Medicare database. A 5% random sample (n=255,702) of persons residing in SEER locations were selected for comparison. For each risk factor, odds ratios (ORs), 95% confidence intervals (95% CI) and PAFs were calculated. RESULTS: As anticipated, the risk of HCC was increased in relationship to each factor: HCV (OR 39.89, 95% CI: 36.29-43.84), HBV (OR 11.17, 95% CI: 9.18-13.59), alcohol-related disorders (OR 4.06, 95% CI: 3.82-4.32), rare metabolic disorders (OR 3.45, 95% CI: 2.97-4.02), and diabetes and/or obesity (OR 2.47, 95% CI: 2.34-2.61). The PAF of all factors combined was 64.5% (males 65.6%; females 62.2%). The PAF was highest among Asians (70.1%) and lowest among black persons (52.4%). Among individual factors, diabetes/obesity had the greatest PAF (36.6%), followed by alcohol-related disorders (23.5%), HCV (22.4%), HBV (6.3%) and rare genetic disorders (3.2%). While diabetes/obesity had the greatest PAF among both males (36.4%) and females (36.7%), alcohol-related disorders had the second greatest PAF among males (27.8%) and HCV the second greatest among females (28.1%). Diabetes/obesity had the greatest PAF among whites (38.9%) and Hispanics (38.1%), while HCV had the greatest PAF among Asians (35.4%) and blacks (34.9%). The second greatest PAF was alcohol-related disorders in whites (25.6%), Hispanics (30.1%) and blacks (and 18.5%) and HBV in Asians (28.5%). CONCLUSIONS: The dominant risk factors for HCC in the United States among persons ≥68 years differ by sex and race/ethnicity. Overall, eliminating diabetes/obesity could reduce the incidence of HCC more than the elimination of any other factor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, Y., & Beydoun, M. A. (2007) · Epidemiologic Reviews · doi:10.1093/epirev/mxm007 · Cited by 2,792
Primary liver cancer: Worldwide incidence and trends
Bosch, F. X., Ribes, J., Díaz, M., & Cléries, R. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.011 · Cited by 2,477
Warren, J. L., Klabunde, C. N., Schrag, D., Bach, P. B., & Riley, G. F. (2002) · PubMed · doi:10.1097/01.mlr.0000020942.47004.03 · Cited by 1,714
Altekruse, S. F., McGlynn, K. A., & Reichman, M. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.7753 · Cited by 1,694
Self-citationTobacco smoke and involuntary smoking.
(2004) · PubMed · Cited by 1,360
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
Starley, B. Q., Calcagno, C. J., & Harrison, S. A. (2010) · Hepatology · doi:10.1002/hep.23594 · Cited by 1,336
Ascha, M. S., Hanouneh, I. A., Lopez, R., Tamimi, T. A.-R., Feldstein, A. F., & Zein, N. N. (2010) · Hepatology · doi:10.1002/hep.23527 · Cited by 1,296
Estimating the population attributable risk for multiple risk factors using case-control data.
BRUZZI, P., GREEN, S. B., BYAR, D. P., BRINTON, L. A., & SCHAIRER, C. (1985) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114174 · Cited by 1,214
PROPORTION OF DISEASE CAUSED OR PREVENTED BY A GIVEN EXPOSURE, TRAIT OR INTERVENTION1
MIETTINEN, O. S. (1974) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a121617 · Cited by 1,036
El–Serag, H. B., Hampel, H., & Javadi, F. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2005.12.007 · Cited by 826
Self-citationHassan, M. M., Hwang, L.-Y., Hatten, C. J., Swaim, M., Li, D., Abbruzzese, J. L., Beasley, P., & Patt, Y. Z. (2002) · Hepatology · doi:10.1053/jhep.2002.36780 · Cited by 762
Alcohol and hepatocellular carcinoma
Morgan, T. R., Mandayam, S., & Jamal, M. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.020 · Cited by 625
Welzel, T. M., Graubard, B. I., Zeuzem, S., El-Serag, H. B., Davila, J. A., & McGlynn, K. A. (2011) · Hepatology · doi:10.1002/hep.24397 · Cited by 543
Self-citationEthnicity and health disparities in alcohol research.
Chartier, K. G., & Caetano, R. (2010) · PubMed · Cited by 476
The Global Epidemiology of Hepatocellular Carcinoma: Present and Future
McGlynn, K. A., & London, W. T. (2011) · Clinics in Liver Disease · doi:10.1016/j.cld.2011.03.006 · Cited by 471
Self-citationWang, C., Wang, X., Gong, G., Ben, Q., Qiu, W., Chen, Y., Li, G., & Wang, L. (2012) · International Journal of Cancer · doi:10.1002/ijc.26165 · Cited by 449
Characteristics of Patients With Nonalcoholic Steatohepatitis Who Develop Hepatocellular Carcinoma
Yasui, K., Hashimoto, E., Komorizono, Y., Koike, K., Arii, S., Imai, Y., Shima, T., Kanbara, Y., Saibara, T., Mori, T., et al. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.01.023 · Cited by 420
Tanaka, M., Katayama, F., Kato, H., Tanaka, H., Wang, J., Qiao, Y. L., & Inoue, M. (2011) · Journal of Epidemiology · doi:10.2188/jea.je20100190 · Cited by 304
Schutze, M., Boeing, H., Pischon, T., Rehm, J., Kehoe, T., Gmel, G., Olsen, A., Tjonneland, A. M., Dahm, C. C., Overvad, K., et al. (2011) · BMJ · doi:10.1136/bmj.d1584 · Cited by 274
Donato, F., Tagger, A., Chiesa, R., Ribero, M. L., Tomasoni, V, Fasola, M., Gelatti, U., Portera, G., Boffetta, P., & Nardi, G. (1997) · Hepatology · doi:10.1002/hep.510260308 · Cited by 234
Trichopoulos, D., Bamia, C., Lagiou, P., Fedirko, V., Trepo, E., Jenab, M., Pischon, T., Nothlings, U., Overved, K., Tjonneland, A., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr395 · Cited by 228
Hepatitis Viruses, Alcohol, and Tobacco in the Etiology of Hepatocellular Carcinoma in Italy
Franceschi, S., Montella, M., Polesel, J., La Vecchia, C., Crispo, A., Dal Maso, L., Casarin, P., Izzo, F., Tommasi, L. G., Chemin, I., et al. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0702 · Cited by 162
Diabetes and liver disease: An ominous association
Moscatiello, S., Manini, R., & Marchesini, G. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2006.08.004 · Cited by 139
Hepatocellular carcinoma in non‐alcoholic steatohepatitis: Growing evidence of an epidemic?
Hashimoto, E., & Tokushige, K. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00872.x · Cited by 128
Calle, E. E., Teras, L. R., & Thun, M. J. (2005) · New England Journal of Medicine · doi:10.1056/nejm200511173532020 · Cited by 126
McQuillan, G. M., Kruszon‐Moran, D., Kottiri, B. J., Curtin, L. R., Lucas, J. W., & Kington, R. S. (2004) · American Journal of Public Health · doi:10.2105/ajph.94.11.1952 · Cited by 122
Differences In Disease Prevalence As A Source Of The U.S.-European Health Care Spending Gap
Thorpe, K. E., Howard, D. H., & Galactionova, K. (2007) · Health Affairs · doi:10.1377/hlthaff.26.6.w678 · Cited by 77
Standard Errors for Attributable Risk for Simple and Complex Sample Designs
Graubard, B. I., & Fears, T. R. (2005) · Biometrics · doi:10.1111/j.1541-0420.2005.00355.x · Cited by 73
Self-citationAttributable risks for hepatocellular carcinoma in Northern Italy
Braga, C., Vecchia, C. L., Negri, E., & Franceschi, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00500-x · Cited by 61
Tracing hepatitis C and Delta viruses to estimate their contribution in HCC rates in Mongolia
Kurbanov, F., Tanaka, Y., Elkady, A., Oyunsuren, T., & Mizokami, M. (2007) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2007.00864.x · Cited by 29
Autoimmune Hepatitis, Cirrhosis, and Hepatocellular Carcinoma (HCC)
Trivedi, P. J., & Cullen, S. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1476-y · Cited by 19
Cited by
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
“For example, liver cancer incidence rates in these populations are double those in non-Hispanic whites, reflecting a higher prevalence of risk factors such as chronic infection with hepatitis B and/or hepatitis C viruses, obesity, diabetes, and binge drinking.(66) AI/ANs have the highest rates of kidney cancer, althou…”
BackgroundEASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Llovet, J. M., Kelley, R. K., Villanueva, A., Singal, A. G., Pikarsky, E., Roayaie, S., Lencioni, R., Koike, K., Zucman-Rossi, J., & Finn, R. S. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00240-3 · Cited by 7,055
Marrero, J. A., Kulik, L. M., Sirlin, C. B., Zhu, A. X., Finn, R. S., Abecassis, M. M., Roberts, L. R., & Heimbach, J. K. (2018) · Hepatology · doi:10.1002/hep.29913 · Cited by 4,539
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Yang, J. D., Hainaut, P., Gores, G. J., Amadou, A., Plymoth, A., & Roberts, L. R. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0186-y · Cited by 4,228
Metadata
- Authors
- Welzel, T. M., Graubard, B. I., Quraishi, S., Zeuzem, S., Davila, J. A., El-Serag, H. B., & McGlynn, K. A.
- Venue
- American Journal of Gastroenterology
- Published
- 2013-08
- Volume
- 108
- Issue
- 8
- Pages
- 1314-1321
- ISSN
- 0002-9270 (ISSN-L)
- OpenAlex
- W1974651000
- Cited by
- 328
- References
- 31
- FWCI
- 16.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.